Name of the Condition
- Subacute and chronic melioidosis
Summary
Subacute and chronic melioidosis is a form of melioidosis caused by Burkholderia pseudomallei, a gram-negative bacterium. It presents with a slower onset and prolonged course compared to acute forms, often involving localized or disseminated infection. The condition may affect multiple organ systems, including the lungs, skin, or joints, and can persist for weeks to months if not adequately treated.
Causes
Subacute and chronic melioidosis is caused by Burkholderia pseudomallei, which is endemic in soil and water in tropical regions. Infection occurs through inhalation, ingestion, or skin inoculation of contaminated material. The bacteria can establish persistent infection, leading to subacute or chronic disease, particularly in individuals with underlying risk factors.
Risk Factors
- Residing in or traveling to tropical regions where Burkholderia pseudomallei is endemic (e.g., Southeast Asia, northern Australia).
- Underlying conditions such as diabetes, chronic lung disease, or immunosuppression, which increase susceptibility to prolonged infection.
- Prolonged environmental exposure (e.g., occupational or recreational contact with contaminated soil or water).
Symptoms
- Persistent fever and fatigue
- Chronic cough or respiratory symptoms
- Skin lesions or abscesses
- Joint pain or swelling
- Weight loss or malaise
Diagnosis
Diagnosis is based on clinical suspicion, exposure history, and laboratory testing. Confirmation may involve culturing Burkholderia pseudomallei from clinical specimens (e.g., blood, sputum, or tissue). Imaging studies (e.g., chest X-ray or CT) may identify localized infections, such as pulmonary nodules or abscesses. Serological tests or molecular assays (e.g., PCR) can support diagnosis in subacute or chronic cases.
Treatment Options
Treatment typically involves prolonged antibiotic therapy, often with intravenous agents (e.g., ceftazidime or meropenem) followed by oral antibiotics (e.g., trimethoprim-sulfamethoxazole) for several months. Surgical drainage may be necessary for localized abscesses or infected tissues. Close monitoring is required to ensure resolution and prevent relapse.
Prognosis and Follow-Up
Prognosis depends on the extent of infection, underlying health, and timely treatment. Chronic or disseminated disease may require extended therapy and follow-up to monitor for relapse. Regular clinical and laboratory evaluations are recommended to assess response to treatment and detect complications.
Complications
- Chronic lung disease or respiratory failure
- Recurrent abscesses or tissue damage
- Septic arthritis or osteomyelitis
- Multi-organ involvement in severe cases
Lifestyle & Prevention
- Avoid contact with contaminated soil or water in endemic regions.
- Use protective measures (e.g., gloves, masks) during high-risk activities (e.g., farming or construction).
- Manage underlying conditions (e.g., diabetes) to reduce susceptibility.
- Seek prompt medical care for persistent symptoms after travel to tropical areas.
When to Seek Professional Help
Consult a healthcare provider if you experience persistent fever, respiratory symptoms, or skin lesions after exposure to endemic regions. Early evaluation is critical for effective treatment and to prevent progression to severe disease.
Tips for Medical Coders
Document the clinical context, including exposure history, symptom duration, and organ system involvement, to support coding for subacute or chronic melioidosis. Ensure specificity in coding based on the patient’s presentation and diagnostic findings. Note that this code is distinct from acute forms and requires clear documentation of the subacute or chronic nature of the infection.